Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease
Authors:
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 271, 145-154
Abstract
No abstract availableKeywords
Funding Information
- Chinese National Foundation of National Sciences Grants (81200246)
- Specialized Research Fund for the Doctoral Programme of Higher Education (20122104120004)
- Project of Science and Technology Department of Liaonin, China (2013010025-401)
This publication has 59 references indexed in Scilit:
- Activation of PARP by Oxidative Stress Induced by β-Amyloid: Implications for Alzheimer’s DiseaseNeurochemical Research, 2012
- β-amyloid activates PARP causing astrocytic metabolic failure and neuronal deathBrain, 2011
- Adenosine A2AReceptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase PathwayJournal of Neuroscience, 2009
- Parthanatos, a messenger of deathFrontiers in Bioscience-Landmark, 2009
- Pyruvate protection against β‐amyloid‐induced neuronal death: Role of mitochondrial redox stateJournal of Neuroscience Research, 2003
- β-Amyloid Neurotoxicity Is Exacerbated during Glycolysis Inhibition and Mitochondrial Impairment in the Rat Hippocampus in Vivo and in Isolated Nerve Terminals: Implications for Alzheimer's DiseaseExperimental Neurology, 2002
- Energetics in the pathogenesis of neurodegenerative diseasesTrends in Neurosciences, 2000
- Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic miceNature Neuroscience, 1999
- Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecinBritish Journal of Cancer, 1999
- Hydrogen peroxide mediates amyloid β protein toxicityCell, 1994